Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents

Objective To report the clinical features of anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in patients ≤ 18 years old. Methods Information was obtained by the authors or referring physicians. Antibodies were determined by immunocytochemistry and enzyme‐linked immunosorbent assay (ELISA) using HEK293 cells ectopically expressing NR1. Results Over an 8‐month period, 81 patients (12 male) with anti‐NMDAR encephalitis were identified....